Clinical trial

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

NCT00003231

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record docetaxel Normalized identity: docetaxelView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention surgical procedure Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-04-01

PhasePHASE2

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

cisplatinDRUG · verified · RxNorm: cisplatin

docetaxelDRUG · verified · RxNorm: docetaxel

surgical procedurePROCEDURE

radiation therapyRADIATION

Sponsors & collaborators

Swiss Cancer Institutelead sponsor

Mapped research locations

ZurichSwitzerland2 BaselSwitzerland2 BernSwitzerland1 GenevaSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003231 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.